Net Cash Provided by (Used in) Operating Activities |
-312K |
USD |
-117% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-25K |
USD |
+98.5% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-9K |
USD |
0% |
Dec 31, 2023 |
Q4 2023 |
Common Stock, Shares Authorized |
300M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
300M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Dec 31, 2022 |
Q4 2022 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-337K |
USD |
-346% |
Mar 31, 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
16K |
USD |
-63.6% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
510K |
USD |
+36% |
Dec 31, 2023 |
Q4 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Dec 31, 2023 |
Q4 2023 |
Depreciation |
18K |
USD |
-43.8% |
Dec 31, 2023 |
Q4 2023 |
Payments to Acquire Property, Plant, and Equipment |
9K |
USD |
0% |
Dec 31, 2023 |
Q4 2023 |
Property, Plant and Equipment, Gross |
168K |
USD |
+2.44% |
Dec 31, 2023 |
Q4 2023 |
Current State and Local Tax Expense (Benefit) |
14K |
USD |
-75.4% |
Dec 31, 2023 |
Q4 2023 |
Current Federal Tax Expense (Benefit) |
113K |
USD |
-84.8% |
Dec 31, 2022 |
Q4 2022 |
Interest Expense |
64K |
USD |
-65.6% |
Mar 31, 2024 |
Q1 2024 |